Innoviva Inc. Stock
Innoviva Inc. Stock
The price for the Innoviva Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.690%).
Currently there is a rather positive sentiment for Innoviva Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 30 € there is potential for a 111.27% increase which would mean more than doubling the current price of 14.2 € for Innoviva Inc..
Pros and Cons of Innoviva Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innoviva Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innoviva Inc. | -0.690% | 0.000% | 3.650% | 35.238% | -2.740% | 48.691% | - |
| Gritstone Oncology Inc | 13.680% | 16.156% | -19.102% | -60.022% | -52.018% | -88.090% | - |
| Avid Bioservices Inc | 0.700% | 5.109% | 24.138% | -55.556% | 18.033% | -60.000% | 78.174% |
| Pacira Pharmaceuticals | 3.310% | 4.167% | -3.101% | -39.614% | -16.107% | -50.000% | -41.038% |
Comments
Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva, Inc. (NASDAQ: INVA) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $22.50 price target on the stock.
Show more
Ratings data for INVA provided by MarketBeat
